These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28529751)

  • 21. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of hormonal contraception on endometrial histology in patients with Lynch syndrome, a retrospective pilot study.
    Mawet M; Evrevin C; Dardenne A; Kridelka F; Pintiaux A; Chabbert-Buffet N
    Fam Cancer; 2024 Apr; ():. PubMed ID: 38687437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers.
    Geurts-Giele WR; Leenen CH; Dubbink HJ; Meijssen IC; Post E; Sleddens HF; Kuipers EJ; Goverde A; van den Ouweland AM; van Lier MG; Steyerberg EW; van Leerdam ME; Wagner A; Dinjens WN
    J Pathol; 2014 Dec; 234(4):548-59. PubMed ID: 25111426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The gynecological surveillance of women with Lynch syndrome in Sweden.
    Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
    Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling.
    Johnatty SE; Tan YY; Buchanan DD; Bowman M; Walters RJ; Obermair A; Quinn MA; Blomfield PB; Brand A; Leung Y; Oehler MK; ; Kirk JA; O'Mara TA; Webb PM; Spurdle AB
    Gynecol Oncol; 2017 Nov; 147(2):381-387. PubMed ID: 28822557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors.
    Sloan EA; Ring KL; Willis BC; Modesitt SC; Mills AM
    Am J Surg Pathol; 2017 Mar; 41(3):326-333. PubMed ID: 27984238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicalpathological characteristics of Lynch syndrome related epithelial ovarian cancer].
    Ma XG; Wang YM; Xue FX; Zhang HY; Sheng HN; Qi Z; Liu GY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):201-4. PubMed ID: 22781072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Converging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas.
    Niskakoski A; Pasanen A; Porkka N; Eldfors S; Lassus H; Renkonen-Sinisalo L; Kaur S; Mecklin JP; Bützow R; Peltomäki P
    Gynecol Oncol; 2018 Jul; 150(1):92-98. PubMed ID: 29716739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age.
    Goverde A; Spaander MC; van Doorn HC; Dubbink HJ; van den Ouweland AM; Tops CM; Kooi SG; de Waard J; Hoedemaeker RF; Bruno MJ; Hofstra RM; de Bekker-Grob EW; Dinjens WN; Steyerberg EW; Wagner A;
    Gynecol Oncol; 2016 Dec; 143(3):453-459. PubMed ID: 27789085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for Lynch syndrome among patients with newly diagnosed endometrial cancer: a comprehensive review.
    Aguirre E; Graña B; Boudet M; Balmaña J
    Tumori; 2016 Nov; 102(6):548-554. PubMed ID: 26219573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
    Jin W; Wang LQ; Liu Y; Liu AJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
    [No Abstract]   [Full Text] [Related]  

  • 33. Analysis of Lynch Syndrome Mismatch Repair Genes in Women with Endometrial Cancer.
    Rubio I; Ibáñez-Feijoo E; Andrés L; Aguirre E; Balmaña J; Blay P; Llort G; González-Santiago S; Maortua H; Tejada MI; Martinez-Bouzas C
    Oncology; 2016; 91(3):171-6. PubMed ID: 27398995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel deleterious c.2656G>T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome.
    Rashid MU; Naeemi H; Muhammad N; Loya A; Yusuf MA; Lubiński J; Jakubowska A; Hamann U
    Hered Cancer Clin Pract; 2016; 14():14. PubMed ID: 27413415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Pathologic Features of Hispanic Endometrial Cancer Patients With Loss of Mismatch Repair Expression.
    Kost ER; Valente PT; Lynch BA; Krishnegowda NK; Hertz AM; Hall KL; Riddle ND; Tekmal RR
    Int J Gynecol Cancer; 2016 Jul; 26(6):1129-36. PubMed ID: 27327152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Importance of Distinguishing Sporadic Cancers from Those Related to Cancer Predisposing Germline Mutations.
    Sorscher S
    Oncologist; 2018 Nov; 23(11):1266-1268. PubMed ID: 29866945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
    Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
    Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.
    Watkins JC; Yang EJ; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Syngal S; Yurgelun MB; Chittenden A; Hornick JL; Crum CP; Sholl LM; Howitt BE
    Int J Gynecol Pathol; 2017 Mar; 36(2):115-127. PubMed ID: 27556954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale for evaluating breast cancers of Lynch syndrome patients for mismatch repair gene expression.
    Sorscher S
    Breast Cancer Res Treat; 2019 Nov; 178(2):469-471. PubMed ID: 31392519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current clinical topics of Lynch syndrome.
    Tanakaya K
    Int J Clin Oncol; 2019 Sep; 24(9):1013-1019. PubMed ID: 29744602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.